Want to see JP:4594 full AI Analyst Report?
BrightPath Biotherapeutics Co.Ltd. (4594) Financial Statements
BrightPath Biotherapeutics Co.Ltd. Financial Overview
BrightPath Biotherapeutics Co.Ltd.'s market cap is currently $5.56B. The company's EPS TTM is $-11.56; its P/E ratio is -3.13; BrightPath Biotherapeutics Co.Ltd. has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Mar 26 | Mar 25 | Mar 24 | Mar 23 | Mar 22 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 84.00K | $ 1.13M | $ 72.00K | $ 5.28M | $ 15.41M |
| Gross Profit | $ 55.00K | $ 1.10M | $ -341.00K | $ -13.33M | $ -23.03M |
| Operating Income | $ -1.29B | $ -1.16B | $ -1.16B | $ -1.47B | $ -1.48B |
| EBITDA | $ -1.30B | $ -1.15B | $ -1.17B | $ -1.47B | $ -1.45B |
| Net Income | $ -1.30B | $ -1.15B | $ -1.17B | $ -1.49B | $ -1.48B |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 2.16B | $ 810.47M | $ 1.06B | $ 1.53B | $ 2.31B |
| Total Assets | $ 2.60B | $ 1.12B | $ 1.23B | $ 1.70B | $ 2.77B |
| Total Debt | $ 0.00 | $ 25.00M | $ 112.50M | $ 0.00 | $ 87.50M |
| Net Debt | $ -2.16B | $ -785.47M | $ -944.86M | $ -1.53B | $ -2.22B |
| Total Liabilities | $ 236.41M | $ 195.62M | $ 251.27M | $ 133.91M | $ 239.73M |
| Stockholders' Equity | $ 2.37B | $ 924.99M | $ 978.99M | $ 1.57B | $ 2.53B |
| Cash Flow | |||||
| Free Cash Flow | $ -1.37B | $ -1.25B | $ -1.16B | $ -1.21B | $ -1.53B |
| Operating Cash Flow | $ -1.37B | $ -1.25B | $ -1.16B | $ -1.20B | $ -1.51B |
| Investing Cash Flow | $ -1.93M | $ -1.37M | $ -7.65M | $ -1.76M | $ -17.57M |
| Financing Cash Flow | $ 2.71B | $ 1.00B | $ 690.96M | $ 432.10M | $ 569.23M |
Currency in JPY